Pulmonary Arterial Hypertension
Oxford University Press
This Oxford University Press app-book, Pulmonary Arterial Hypertension, is developed by MedHand. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using MedHand's patented technology.
THIS APP-BOOK includes unique functions such as:
- A powerful search
- Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
- Notes and picture notes
About this title
- Written by highly respected UK and World experts within the pulmonary arterial hypertension (PAH) field this comprehensive but concise guide includes the basics of aetiology, clinical course, diagnosis and management of PAH including summary tables, schematic figures and contemporary references for further reading.
- Helpful key points at the start of each chapter.
This concise app-book provides an easily accessible resource on pulmonary arterial hypertension (PAH) for medical professionals (senior and trainees), nurses and allied disciplines. PAH is not any longer an orphan disease, nor is it associated with a grave prognosis and premature death (as it used to be the case a decade or two ago). Patients with PAH should enjoy improved survival and quality of life, provided that an early -and not late- diagnosis is made combined with timely initiation of advanced therapy in specialized/designated tertiary centres.
This comprehensive text incorporates PAH expertise from the UK and the rest of the world. The book outlines the key points with respect to the latest classification, pathobiology, genetics, clinical assessment of the patient with suspected PAH and the role of imaging. There are specific chapters addressing different PAH aetiologies, namely idiopathic PAH, thromboembolic PAH, PAH related to connective tissue disease, congenital heart disease (Eisenmenger complex), respiratory disease and other unusual causes. Last, but not least, the book addresses counselling, contraception and the latest therapy for the challenging area of pregnancy and PAH, which is still associated with a high maternal mortality risk.
Authors: Michael A. Gatzoulis